Article Details

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody ...

Retrieved on: 2020-12-17 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody .... View article details on hiswai:

Excerpt

By utilizing Glycotope's antibody, ONK can tailor its CAR to target the ... to develop highly tumor-specific <b>monoclonal antibodies</b> called GlycoBodies.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up